Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALVAGE trial of icosapent ethyl for slowing aortic valve stenosis progression
NL-OMON60000Phase 2Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of omega-3-acid triglycerides in aortic stenosis (AS), sponsored by Amsterdam University Medical Center. Started Sep 2024; status: recruiting.
02
Drugs
omega-3-acid triglycerides
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NL-OMON60000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60000.